Evidence map›Paper›PMID 29117791›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2018

Implementing Generalized Additive Models to Estimate the Expected Value of Sample Information in a Microsimulation Model: Results of Three Case Studies.

Dustin J Rabideau, Pamela P Pei, Rochelle P Walensky, Amy Zheng, Robert A Parker

Abstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dustin J RabideauBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA (DJR, RAP).
Pamela P PeiMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA (PPP, RPW, AZ, RAP).
Rochelle P WalenskyMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA (PPP, RPW, AZ, RAP).
Amy ZhengMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA (PPP, RPW, AZ, RAP).
Robert A ParkerBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA (DJR, RAP).
Brigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

Novel Methods to Inform HIV/TB Clinical Trial DevelopmentR01AI093269 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI REDDY, KRISHNA P · 2011 to 2024
$6.8M
Novel Methods to Inform HIV/TB Clinical Trial DevelopmentR37AI093269 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALENSKY, ROCHELLE P. · 2015 to 2019
$3.8M
NIAID NIH HHS R01 AI093269NIAID NIH HHS R37 AI093269
6 · The paper itself

Abstract

backgroundThe expected value of sample information (EVSI) can help prioritize research but its application is hampered by computational infeasibility, especially for complex models. We investigated an approach by Strong and colleagues to estimate EVSI by applying generalized additive models (GAM) to results generated from a probabilistic sensitivity analysis (PSA).

methodsFor 3 potential HIV prevention and treatment strategies, we estimated life expectancy and lifetime costs using the Cost-effectiveness of Preventing AIDS Complications (CEPAC) model, a complex patient-level microsimulation model of HIV progression. We fitted a GAM-a flexible regression model that estimates the functional form as part of the model fitting process-to the incremental net monetary benefits obtained from the CEPAC PSA. For each case study, we calculated the expected value of partial perfect information (EVPPI) using both the conventional nested Monte Carlo approach and the GAM approach. EVSI was calculated using the GAM approach.

resultsFor all 3 case studies, the GAM approach consistently gave similar estimates of EVPPI compared with the conventional approach. The EVSI behaved as expected: it increased and converged to EVPPI for larger sample sizes. For each case study, generating the PSA results for the GAM approach required 3 to 4 days on a shared cluster, after which EVPPI and EVSI across a range of sample sizes were evaluated in minutes. The conventional approach required approximately 5 weeks for the EVPPI calculation alone.

conclusionEstimating EVSI using the GAM approach with results from a PSA dramatically reduced the time required to conduct a computationally intense project, which would otherwise have been impractical. Using the GAM approach, we can efficiently provide policy makers with EVSI estimates, even for complex patient-level microsimulation models.

Indexed as

Decision Support TechniquesModels, TheoreticalAlgorithmsAlkynesBenzoxazinesCyclopropanesDrug SubstitutionFemaleFinancing, PersonalHumansPre-Exposure ProphylaxisReverse Transcriptase InhibitorsAlkynesBenzoxazinesCyclopropanesefavirenzReverse Transcriptase InhibitorsEVSIGAMHIVvalue of information

Identifiers

PMID29117791
PMCPMC5771838
OpenAlexW2768074928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.